CN111632065A - Antipyretic formula - Google Patents
Antipyretic formula Download PDFInfo
- Publication number
- CN111632065A CN111632065A CN202010562986.7A CN202010562986A CN111632065A CN 111632065 A CN111632065 A CN 111632065A CN 202010562986 A CN202010562986 A CN 202010562986A CN 111632065 A CN111632065 A CN 111632065A
- Authority
- CN
- China
- Prior art keywords
- parts
- mixture
- antipyretic
- antioxidant
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001754 anti-pyretic effect Effects 0.000 title claims abstract description 34
- 239000002221 antipyretic Substances 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 38
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 229930006000 Sucrose Natural products 0.000 claims abstract description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 18
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 14
- 238000005303 weighing Methods 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000007789 sealing Methods 0.000 claims abstract description 10
- 238000004806 packaging method and process Methods 0.000 claims abstract description 9
- 239000004744 fabric Substances 0.000 claims abstract description 5
- 239000012467 final product Substances 0.000 claims abstract description 5
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical group [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims abstract description 5
- 229940001584 sodium metabisulfite Drugs 0.000 claims abstract description 5
- 235000010262 sodium metabisulphite Nutrition 0.000 claims abstract description 5
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 11
- 239000004745 nonwoven fabric Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 3
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 5
- 206010037660 Pyrexia Diseases 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 3
- 208000007407 African swine fever Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241001115402 Ebolavirus Species 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 239000003998 snake venom Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000013559 Schnittsellerie Nutrition 0.000 description 1
- 244000169997 Schnittsellerie Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an antipyretic formula which is prepared from the following raw materials in parts by mass: 4-10 parts of refined salt; 1-2 parts of white sugar; 2-3 parts of vitamin C; 0.5-1 part of antioxidant. Preferably, the antioxidant is sodium metabisulfite. The preparation method of the antipyretic formula comprises the following steps: (1) weighing 4-10 parts by mass of refined salt, weighing 1-2 parts by mass of white sugar, uniformly mixing the refined salt and the white sugar to obtain a mixture A, and filling the mixture A into a first non-woven cloth bag for sealing; (2) weighing 2-3 parts of vitamin C, adding 0.5-1 part of antioxidant, uniformly mixing to obtain a mixture B, and filling the mixture B into a second non-woven bag for sealing; (3) sterilizing the first and second non-woven bags and their contents, packaging in waterproof and dampproof bags, and vacuum preserving to obtain the final product. The invention has the advantages of safe raw materials, no toxic or side effect, simple preparation method, convenient taking and wide application range, and is suitable for various diseases with fever as the main symptom.
Description
Technical Field
The invention relates to the technical field of medicines, in particular to an antipyretic formula.
Background
When a human body has a cold, the body temperature is usually over 38.5 ℃, most patients take an antipyretic or hang water, the antipyretic is a medicine which can expand blood vessels on the body surface of the human body by adjusting the function of the human body, further increase heat dissipation by virtue of processes of sweating and the like, inhibit chills and reduce heat production of the body, but the antipyretic is accompanied by toxic and side effects such as drug eruption, gastrointestinal tract reaction, blood system reaction, damage to liver and kidney functions and the like, and particularly when the antipyretic is used for a long time or is used excessively, the toxic and side effects are more obvious. At present, a plurality of traditional Chinese medicine fever reducing formulas have different qualities and certain toxic and side effects, and are not suitable for children of small age.
Therefore, there is a need to develop a method for reducing the body temperature of a patient with safe raw materials and good antipyretic effect.
Disclosure of Invention
In order to solve the existing problems, the invention provides an antipyretic formula. The invention is realized by the following technical scheme.
The antipyretic formula is prepared from the following raw materials in parts by mass: 4-10 parts of refined salt; 1-2 parts of white sugar; 2-3 parts of vitamin C; 0.5-1 part of antioxidant.
Preferably, the formula is prepared from the following raw materials in parts by mass: 6 parts of refined salt; 1.5 parts of white sugar; 2 parts of vitamin C; 0.8 part of antioxidant.
More preferably, the antioxidant is sodium metabisulfite.
The preparation method of the antipyretic formula comprises the following steps:
(1) weighing 4-10 parts by mass of refined salt, weighing 1-2 parts by mass of white sugar, uniformly mixing the refined salt and the white sugar to obtain a mixture A, and filling the mixture A into a first non-woven cloth bag for sealing;
(2) weighing 2-3 parts of vitamin C, adding 0.5-1 part of antioxidant, uniformly mixing to obtain a mixture B, and filling the mixture B into a second non-woven bag for sealing;
(3) sterilizing the first and second non-woven bags and their contents, packaging in waterproof and dampproof bags, and vacuum preserving to obtain the final product.
The application method of the antipyretic composition prepared by the preparation method comprises opening the external waterproof and moistureproof packaging bag, pouring the mixture A in the first non-woven fabric bag into 100-200 parts of warm water, stirring uniformly, adding the mixture in the second non-woven fabric bag, stirring uniformly, and taking orally.
More preferably, the water is mineral water, tap water, ionized water, or distilled water.
The invention has the beneficial effects that:
the antipyretic composition is prepared by taking refined salt as a main raw material and white sugar, vitamins and an antioxidant as auxiliary materials, dissolving the refined salt in drinking water such as mineral water, tap water, ionized water or distilled water and the like, and processing the antipyretic composition, has the advantages of safe raw materials, no toxic or side effect, simple preparation method, convenient taking and wide application range, and is suitable for various diseases taking fever as a main symptom: such as common influenza, encephalitis, lymphoma, African swine fever, lupus erythematosus, Ebola virus, avian influenza, snake venom, cough and the like, and has wide popularization prospect.
Detailed Description
The technical solution of the present invention will be described in more detail and fully with reference to the following embodiments.
The specific embodiment 1 is an antipyretic formula which is prepared from the following raw materials in parts by mass: 6g of refined salt; 1.5g of white sugar; 2g of vitamin C and 0.8g of sodium metabisulfite.
The preparation method of the antipyretic formula containing the formula comprises the following steps:
(1) weighing 6g of refined salt and 1.5g of white sugar, uniformly mixing the refined salt and the white sugar to obtain a mixture A, filling the mixture A into a first non-woven cloth bag, and sealing;
(2) weighing 2g of vitamin C, adding 0.8g of antioxidant, uniformly mixing to obtain a mixture B, and filling the mixture B into a second non-woven fabric bag for sealing;
(3) sterilizing the first and second non-woven bags and their contents, packaging in waterproof and dampproof bags, and vacuum preserving to obtain the final product.
The using method comprises the following steps:
opening the external waterproof and moistureproof packaging bag, pouring the mixture A in the first non-woven fabric bag into 200g of warm mineral water, uniformly stirring, adding the mixture in the second non-woven fabric bag, and uniformly stirring.
The taking method comprises the following steps: is orally administered three to five times a day.
The main treatment is as follows: fever caused by various diseases. The solution prepared by the formula is matched with an antipyretic patch for use, so that the antipyretic effect is better.
In addition, the composition can also be used for treating eczema, urticaria and other skin diseases with symptoms of itching, redness and swelling and the like, and the solution is required to be smeared on an affected part for 3-5 times in half an hour or one hour when the skin diseases are treated.
The embodiment 2 discloses an antipyretic formula, which is prepared from the following raw materials in parts by mass: 8g of refined salt; 2g of white sugar; 3g of vitamin C and 1g of sodium metabisulfite.
The preparation method of the antipyretic formula containing the formula comprises the following steps:
(1) weighing 8g of refined salt and 2g of white sugar, uniformly mixing the refined salt and the white sugar to obtain a mixture A, filling the mixture A into a first non-woven cloth bag, and sealing;
(2) weighing 3g of vitamin C, adding 1g of antioxidant, uniformly mixing to obtain a mixture B, and filling the mixture B into a second non-woven fabric bag for sealing;
(3) sterilizing the first and second non-woven bags and their contents, packaging in waterproof and dampproof bags, and vacuum preserving to obtain the final product.
The using method comprises the following steps:
and opening the external waterproof and moistureproof packaging bag, pouring the mixture A in the first non-woven fabric bag into 200g of warm ionized water, uniformly stirring, adding the mixture in the second non-woven fabric bag, and uniformly stirring.
The taking method comprises the following steps: is orally administered three to five times a day.
The main treatment is as follows: fever caused by various diseases. The solution prepared by the formula is matched with an antipyretic patch for use, so that the antipyretic effect is better.
In addition, the composition can also be used for treating eczema, urticaria and other skin diseases with symptoms of itching, redness and swelling and the like, and the solution is required to be smeared on an affected part for 3-5 times in half an hour or one hour when the skin diseases are treated.
The technical principle of the invention is as follows: human cells are in a body fluid environment, and the cells and the body fluid are mutually influenced. The action of germs or viruses on human body changes the state of cells and the environment of body fluid, and loses the normal working condition. For example, a human body has fever, and can show high fever without sweat; the internal manifestations are local or total edema-like cell volume, poor water metabolism and swelling of cell volume. If the antipyretic formula is used for dredging, after a human body takes the water prepared by the antipyretic formula, all components are dispersed to all parts of the body, and the cell state and the body fluid environment are changed to be normal.
Note that: during the administration of the antipyretic formula, a large amount of drinking is not recommended, and if drinking, a little salt can be added, and the concentration of the antipyretic formula is slightly higher than that of normal saline; if the patient is accompanied by diarrhea, the patient can take antidiarrheal medicines at the same time; for emesis, the patient can take morpholine; the amount of refined salt in the formula is different according to the weight of the patient and the fever of the patient. The formula mainly treats fever caused by various diseases, such as common infection, influenza, encephalitis, lymph cancer, African swine fever, lupus erythematosus, Ebola virus, avian influenza, snake venom, cough and the like.
It is to be understood that the described embodiments are merely individual embodiments of the invention, rather than all embodiments. All other implementations made by those skilled in the art without any inventive step based on the embodiments of the present invention belong to the protection scope of the present invention.
Claims (6)
1. An antipyretic formula is characterized in that: the formula is prepared from the following raw materials in parts by mass: 4-10 parts of refined salt; 1-2 parts of white sugar; 2-3 parts of vitamin C; 0.5-1 part of antioxidant.
2. An antipyretic formulation according to claim 1, characterised in that: the formula is prepared from the following raw materials in parts by mass: 6 parts of refined salt; 1.5 parts of white sugar; 2 parts of vitamin C; 0.8 part of antioxidant.
3. An antipyretic formulation according to claim 1, characterised in that: the antioxidant is sodium metabisulfite.
4. A method of preparing an antipyretic formulation according to claim 1, characterised in that: the method comprises the following steps:
(1) weighing 4-10 parts by mass of refined salt, weighing 1-2 parts by mass of white sugar, uniformly mixing the refined salt and the white sugar to obtain a mixture A, and filling the mixture A into a first non-woven cloth bag for sealing;
(2) weighing 2-3 parts of vitamin C, adding 0.5-1 part of antioxidant, mixing uniformly to obtain a mixture B, and filling the mixture B into a second non-woven fabric bag for sealing;
(3) sterilizing the first and second non-woven bags and their contents, packaging in waterproof and dampproof bags, and vacuum preserving to obtain the final product.
5. A method of using the antipyretic formulation prepared in claim 4, characterized by: opening the external waterproof and moistureproof packaging bag, pouring the mixture A in the first non-woven fabric bag into 100-200 parts of warm water, uniformly stirring, adding the mixture in the second non-woven fabric bag, uniformly stirring, and orally taking.
6. The method of using an antipyretic formulation as claimed in claim 5, wherein: the water is mineral water, tap water, ionized water or distilled water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010562986.7A CN111632065A (en) | 2020-06-19 | 2020-06-19 | Antipyretic formula |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010562986.7A CN111632065A (en) | 2020-06-19 | 2020-06-19 | Antipyretic formula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111632065A true CN111632065A (en) | 2020-09-08 |
Family
ID=72323065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010562986.7A Pending CN111632065A (en) | 2020-06-19 | 2020-06-19 | Antipyretic formula |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111632065A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709390A (en) * | 2005-05-31 | 2005-12-21 | 王鹏程 | Medicine for treating cold |
| CN109364080A (en) * | 2018-10-29 | 2019-02-22 | 何凤姣 | A kind of compound cold medicine and preparation method thereof mitigating headache |
-
2020
- 2020-06-19 CN CN202010562986.7A patent/CN111632065A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709390A (en) * | 2005-05-31 | 2005-12-21 | 王鹏程 | Medicine for treating cold |
| CN109364080A (en) * | 2018-10-29 | 2019-02-22 | 何凤姣 | A kind of compound cold medicine and preparation method thereof mitigating headache |
Non-Patent Citations (4)
| Title |
|---|
| 张少华等: "《药物分析实验指导》", 30 September 2017 * |
| 杨如哲: "《健康与合理应用》", 30 April 2004 * |
| 杨铭铎等: "《儿童智力营养与科学配餐》", 31 December 1991 * |
| 骆小丽: "《0-3岁育儿百科》", 30 June 2015 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103880910B (en) | A kind of preparation method and its usage of Cyclosiversigenin | |
| NO124275B (en) | ||
| CN105434465A (en) | Pharmaceutical composition for preventing and treating arthritis and preparation method thereof | |
| CN101810642A (en) | Chinese medicinal preparation for treating canker sores and acute tonsillitis and preparation method thereof | |
| CN111632065A (en) | Antipyretic formula | |
| CN103800510B (en) | A kind of external wash liquid prescription and preparation method | |
| CN102988529B (en) | Preparation method and novel application of total phenolic acid in cherry stones | |
| Fan et al. | Protective effect of Weikang decoction and partial ingredients on model rat with gastric mucosa ulcer | |
| CN106616999A (en) | Monascus polysaccharide compound anti-tumor cancer solid beverage and preparation method thereof | |
| CN108813636A (en) | Beneficial anahemin composition and its application | |
| JP2018138582A (en) | Amylase-activity-inhibiting composition containing chito-oligosaccharide | |
| CN102028706B (en) | Flushing liquid for liver-cancer surgical incisions | |
| CN104857019A (en) | Novel oral rehydration salts solution and preparation method and use thereof | |
| CN109939200B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating acute kidney injury | |
| CN103720716A (en) | Application of modified fulvic acid in preparation of antitumor drugs | |
| CN108635493A (en) | Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application | |
| CN102068537B (en) | The preparation of Pericarpium Citri Reticulatae Radix Glycyrrhizae prevents and treats the health food of nasopharyngeal carcinoma and the production method of medicine | |
| CN100352449C (en) | Medicament composition for treating tinea pedis and tinea corporis | |
| CN104042790B (en) | A kind of pharmaceutical composition and its application for health care for the middle and old aged | |
| CN106496175A (en) | The derivative of scutelloside, Preparation method and use | |
| CN107596080A (en) | A kind of medicament for removing cattle and sheep foot and mouth disease and preparation method thereof | |
| CN102247444A (en) | Medicine for treating burn and scald and preparation method thereof | |
| KR20170136358A (en) | A chinese medicine composition for treating cholecystitis | |
| CN108478729B (en) | A Chinese medicinal composition for resisting oxidation and aging and enhancing immunity, and its preparation method | |
| CN105168430A (en) | Medicine composition for preventing and treating gout and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200908 |
|
| RJ01 | Rejection of invention patent application after publication |